GREYMATTER CAPITAL
GREYMATTER CAPITAL is a Seed, Series A and Series C+ fund in the US and Switzerland writing $250K–$1.2M checks into mental-health, wellness, neurotech and behavioral-health.
- Stages
- Seed, Series A, Series C+
- Sectors
- mental-health, wellness, neurotech, behavioral-health
- Check size
- $250K–$1.2M
- Invests in
- US-wide, Switzerland
- Actively investing
- Yes
- Founded
- 2021
- Website
- greymattercapital.com
Thesis
GreyMatter Capital, founded in 2021, is a venture capital firm exclusively focused on the mental health and emotional wellness sector. Their investment thesis centers on early-stage innovation within mental health, wellness, and neurotech, aiming to address the global challenges in mental well-being. They provide capital, strategic partnerships, and guidance from a multidisciplinary network of clinicians, researchers, technologists, and policy leaders. The firm emphasizes collaboration across research, healthcare, and technology sectors. Geographically, GreyMatter Capital primarily invests in the United States, with some investments in Switzerland. Their typical investment ranges from $250,000 to $1.2 million per company. GreyMatter Fund I is an early-stage venture capital fund, and the firm has a track record of at least 14 investments. They are dedicated to supporting founders who are developing transformative solutions to improve mental, behavioral, and emotional well-being.
Common questions
Does GREYMATTER CAPITAL invest at the Seed stage?
Yes. GREYMATTER CAPITAL lists Seed, Series A and Series C+ among the stages it invests in.
What check size does GREYMATTER CAPITAL write?
GREYMATTER CAPITAL writes $250K–$1.2M checks.
Where does GREYMATTER CAPITAL invest?
GREYMATTER CAPITAL invests in the US and Switzerland.